| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |